Trial Profile
An Observational study, Evaluating Alemtuzumab as Rescue Therapy in a Cohort of 16 Aggressive Multiple Sclerosis Patients who had previously treated with mitoxantrone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 14 Dec 2015 New trial record
- 01 Jan 2015 Status changed from active, no longer recruiting to completed according to results presented at the 2014 Congress of European Neurology.